Dynamic42 and EPO Close the Gap in Brain Cancer Research
One of the key challenges in brain cancer research is the limited availability of preclinical models. Dynamic42 GmbH, based in Jena, Germany, and EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH are addressing this gap through a new…